Survival from cancer in the north region of Portugal: results from the first decade of the millennium
- 1 September 2017
- journal article
- research article
- Published by Wolters Kluwer Health in European Journal Of Cancer Prevention
- Vol. 26, S170-S175
Abstract
The aim of this study was to evaluate net survival from cancer diagnosed during the period 2001–2010 in the north region of Portugal to identify the tumours that need actions to improve the outcomes. Data were retrieved from the North Region Cancer Registry of Portugal database. The top 20 cancer sites in adults were considered: oesophagus, stomach, colon, rectum, pancreas, liver, larynx, lung, skin melanoma, breast, cervix, corpus uteri, ovary, prostate, kidney, bladder, brain and central nervous system, thyroid, non-Hodgkin lymphoma and multiple myeloma. Net survival was estimated using the Pohar–Perme estimator. The effect of diagnosis period was evaluated using flexible parametric models adjusted for age and sex where appropriate. Thyroid and prostate cancers presented the best 5-year survival (>90%), whereas oesophagus, pancreas, liver and lung cancers the worst 5-year survival (<20%). The largest increase in survival was observed for the larynx. A significant decrease in age-adjusted and sex-adjusted excess mortality was observed for stomach, colon, pancreas, larynx, melanoma, breast, brain and central nervous system, thyroid, non-Hodgkin lymphoma and multiple myeloma. For the other cancer sites, no significant trends were observed. For some of these sites, the downward trend in excess mortality was only observed in the short term. An important picture of population-based cancer survival outcomes for the first decade of the millennium in the north region of Portugal was presented in this study. It has been shown that improvements in survival were not universal for all cancer sites. These results should be used to highlight tumours where intervention is needed the most.Keywords
This publication has 26 references indexed in Scilit:
- Trends in Gastric and Esophageal Cancer Incidence in Northern Portugal (1994-2009) by Subsite and Histology, and Predictions for 2015Tumori Journal, 2016
- Age and case mix-standardised survival for all cancer patients in Europe 1999–2007: Results of EUROCARE-5, a population-based studyEuropean Journal of Cancer, 2015
- Survival for oesophageal, stomach and small intestine cancers in Europe 1999–2007: Results from EUROCARE-5European Journal of Cancer, 2015
- Performance indicators evaluation of the population-based breast cancer screening programme in Northern Portugal using the European GuidelinesCancer Epidemiology, 2015
- Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)The Lancet, 2015
- Ovarian cancer in the United States: Contemporary patterns of care associated with improved survivalGynecologic Oncology, 2015
- The impact of life tables adjusted for smoking on the socio-economic difference in net survival for laryngeal and lung cancerBritish Journal of Cancer, 2014
- Randomised controlled trials and population-based observational research: partners in the evolution of medical evidenceBritish Journal of Cancer, 2014
- Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based studyThe Lancet Oncology, 2014
- Standard cancer patient population for age standardising survival ratiosEuropean Journal of Cancer, 2004